144 related articles for article (PubMed ID: 11332205)
1. In vitro transformation of rat renal cells by treatment with ferric nitrilotriacetate.
Kakehashi C; Mori M; Kawabata T; Okada S
Acta Med Okayama; 2001 Apr; 55(2):97-103. PubMed ID: 11332205
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate.
Deguchi J; Kawabata T; Kondo A; Okada S
Jpn J Cancer Res; 1993 Jun; 84(6):649-55. PubMed ID: 8340253
[TBL] [Abstract][Full Text] [Related]
3. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney.
Uchida K; Fukuda A; Kawakishi S; Hiai H; Toyokuni S
Arch Biochem Biophys; 1995 Mar; 317(2):405-11. PubMed ID: 7893156
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone-dependent renal cell carcinogenesis induced by ferric nitrilotriacetate in Wistar rats.
Deguchi J; Miyamoto M; Okada S
Jpn J Cancer Res; 1995 Nov; 86(11):1068-71. PubMed ID: 8567398
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
6. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA).
Randerath E; Watson WP; Zhou GD; Chang J; Randerath K
Mutat Res; 1995 Feb; 341(4):265-79. PubMed ID: 7531286
[TBL] [Abstract][Full Text] [Related]
7. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress.
Athar M; Iqbal M
Carcinogenesis; 1998 Jun; 19(6):1133-9. PubMed ID: 9667754
[TBL] [Abstract][Full Text] [Related]
8. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Luo XP; Tanaka T; Uchida K; Hiai H; Lehotay DC
Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241
[TBL] [Abstract][Full Text] [Related]
9. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.
Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O
Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate.
Tanaka T; Nishiyama Y; Okada K; Satoh K; Fukuda A; Uchida K; Osawa T; Hiai H; Toyokuni S
Carcinogenesis; 1998 May; 19(5):897-903. PubMed ID: 9635880
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme.
Fukuda A; Osawa T; Oda H; Toyokuni S; Satoh K; Uchida K
Arch Biochem Biophys; 1996 May; 329(1):39-46. PubMed ID: 8619633
[TBL] [Abstract][Full Text] [Related]
12. Probucol as a potent inhibitor of oxygen radical-induced lipid peroxidation and DNA damage: in vitro studies.
Iqbal M; Sharma SD; Okada S
Redox Rep; 2004; 9(3):167-72. PubMed ID: 15327747
[TBL] [Abstract][Full Text] [Related]
13. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Uchida K; Okamoto K; Hattori-Nakakuki Y; Hiai H; Stadtman ER
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2616-20. PubMed ID: 8146163
[TBL] [Abstract][Full Text] [Related]
14. Consumption of hydrogen-rich water protects against ferric nitrilotriacetate-induced nephrotoxicity and early tumor promotional events in rats.
Li FY; Zhu SX; Wang ZP; Wang H; Zhao Y; Chen GP
Food Chem Toxicol; 2013 Nov; 61():248-54. PubMed ID: 24140467
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney.
Zhang D; Okada S; Yu Y; Zheng P; Yamaguchi R; Kasai H
Cancer Res; 1997 Jun; 57(12):2410-4. PubMed ID: 9192818
[TBL] [Abstract][Full Text] [Related]
16. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate (Fe-NTA)-mediated DNA damage: implications for carcinogenesis.
Iqbal M; Sharma SD; Mizote A; Fujisawa M; Okada S
Teratog Carcinog Mutagen; 2003; Suppl 1():13-21. PubMed ID: 12616593
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.
Nishiyama Y; Tanaka T; Naitoh H; Mori C; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1997 Feb; 88(2):120-8. PubMed ID: 9119739
[TBL] [Abstract][Full Text] [Related]
18. Copper-nitrilotriacetate (Cu-NTA) is a potent inducer of proliferative response both in liver and kidney but is a complete renal carcinogen.
Giri U; Iqbal M; Athar M
Int J Oncol; 1999 Apr; 14(4):799-806. PubMed ID: 10087332
[TBL] [Abstract][Full Text] [Related]
19. alpha-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress.
Iqbal M; Rezazadeh H; Ansar S; Athar M
Hum Exp Toxicol; 1998 Mar; 17(3):163-71. PubMed ID: 9587785
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis.
Iqbal M; Giri U; Giri DK; Alam MS; Athar M
Arch Biochem Biophys; 1999 May; 365(1):101-12. PubMed ID: 10222044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
